Early-Stage Drug Development: Can Industry-Academia Partnerships Really Bear Enough Fruit?
At this year’s 5th Annual Discovery Partnerships Conference 2014 in Berlin, Dr. Katja
Rosenkranz - Senior Project Manager at Ascenion, will talk about their Spinnovator funding initiative “for spinning off academic technologies”. Ahead of the conference, we asked Dr. Katja Rosenkranz about the major challenges and how to support early-stage drug development programs today.
Pharma IQ: What in your opinion are the major challenges today for enhancing early-stage devel...
To continue reading this story get free access
Please note: That all fields marked with an asterisk (*) are required.